A Study of Eptinezumab in Pediatric Participants With Episodic Migraine (NCT05897320)
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine
🩺 Plain-English Summary (8th-Grade Level)
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
Who can join: Review the eligibility criteria below.
Location: Ki Health Partners LLC DBA New England Institute for Clinical Research — Stamford, Connecticut
Age range: 6 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (64 Sites)
Showing the first 25 of 64 sites.
- Ki Health Partners LLC DBA New England Institute for Clinical Research — Stamford, Connecticut
- Child Neurology of NW Florida — Gulf Breeze, Florida
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave — Hialeah, Florida
- University of South Florida - 13330 USF Laurel Dr — Tampa, Florida
- Clinical Integrative Research Center of Atlanta (CIRCAtl) — Atlanta, Georgia
- University of Kentucky HealthCare (UKHC) Kentucky Clinic — Lexington, Kentucky
- University of Maryland School of Medicine — Baltimore, Maryland
- Michigan Head Pain and Neurological Institute — Ann Arbor, Michigan
- North Suffolk Neurology-Commack — Commack, New York
- OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte — Charlotte, North Carolina
- Childrens Hospital Medical Center of Akron — Akron, Ohio
- Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio
- Road Runner Research Ltd — San Antonio, Texas
- Children's Specialty Group - 3 Commercial Place — Norfolk, Virginia
- Childrens Hospital of Wisconsin - PIN — New Berlin, Wisconsin
- Clínica Privada Independencia — Munro, Buenos Aires
- Instituto Médico Río Cuarto — Río Cuarto, Córdoba Province
- INECO Neurociencias Oroño — Rosario, Santa Fe Province
- Centro de Investigaciones Médicas Tucumán - PPDS — San Miguel de Tucumán, Tucumán Province
- Expertia S.A- Mautalén Salud e Investigación — Buenos Aires,
- Hospital Britanico de Buenos Aires (HOB) — Buenos Aires,
- Hospital de Niños de La Santisima Trinidad — Córdoba,
- Medical Arts Health Research Group - Penticton - PPDS — Penticton, British Columbia
- Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic — Victoria, British Columbia
- The Kids Clinic — Ajax, Ontario
📞 Contact the Study Coordinator
Phone: (453) 630-1311
Email: HQ_Medinfo@Lundbeck.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Episodic Migraine
- A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Huntsville, Alabama
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults — Birmingham, Alabama
- Efficacy of Nerve Blocks for Episodic Migraine — Rochester, Minnesota
- Chiropractic Care for Episodic Migraine — Boston, Massachusetts
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine — Huntsville, Alabama
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine — Chandler, Arizona
Explore by condition: All Episodic Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.